Vaxcyte, Inc. technical analysis
Technical analysis of Vaxcyte, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Vaxcyte, Inc.
Vaxcyte, Inc. is a clinical-stage biopharmaceutical company that develops conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine in development for the prevention of invasive pneumococcal disease in infants, while the company also develops additional vaccine candidates including VAX-31 for adults and children, VAX-A1 against Group A Streptococcus, and other programs in development for additional infectious diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
Vaxcyte, Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
60.47 $
+1.14%
50 sessions
58.19 $
+5.11%
200 sessions
54.07 $
+13.12%
Session levels
s2
58.76
Support
s1
59.97
Support
pivot
61.05
Pivot
r1
62.26
Resistance
r2
63.34
Resistance
How to read it
In the September 4, 2026 session Vaxcyte, Inc. closed lower at 61.16 $, −0.02% versus the previous session.
The price sits above every moving average observed: +1.14% against the 21-session average, +5.11% against the 50 and +13.12% against the 200.
The 14-period RSI reads 56.4, in neutral territory.
MACD stands at 1.108 against a signal line at 1.267: the histogram is negative (−0.159).
ADX reads 36.5, indicating a marked directionality.
Levels computed on the latest session place supports at 59.97 and 58.76 $ and resistances at 62.26 and 63.34 $, around a pivot of 61.05.
The average daily range (ATR) is 2.328 $, or 3.81% of price.
Turnover was 986.7K shares, 103% of the 20-session average.
Over the last twelve months the price ranged between 45.30 and 63.98 $, and today stands −4.41% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the PCVX analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Vaxcyte, Inc.
How is Vaxcyte, Inc. analysed technically?
Technical analysis of Vaxcyte, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Vaxcyte, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Vaxcyte, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Vaxcyte, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.